Navigation Links
Society for Biomolecular Sciences Announces 2008 Conference Speaker Line-up
Date:3/19/2008

Leaders in Biotechnology and Drug Development to Attend April Meeting in St. Louis

DANBURY, Conn., March 19 /PRNewswire-USNewswire/ -- The Society for Biomolecular Sciences (SBS) today announced its outstanding roster of keynote speakers for its 14th Annual Conference & Exhibition to be held April 6-10 at America's Center in St. Louis, MO. More than 2,500 leaders in the pharmaceutical and biotech industries from around the world are expected to attend the 2008 Conference to discuss advances in biotechnology, challenges and automation solutions in the field.

Leading presentations for the five-day event will be Janet Woodcock, M.D., deputy commissioner and chief medical officer for the U.S. Food & Drug Administration. Dr. Woodcock, who oversees scientific and medical regulatory operations for the FDA, will speak on "The Promise of Molecular Medicine." Dr. Woodcock most recently served as the FDA's Deputy Commissioner for Operations and Chief Operating Officer and as the Director of the FDA's Center for Drug Evaluation.

Joining Dr. Woodcock as a keynote speaker will be Jonathan D. Gitlin, M.D., the Helene B. Roberson Professor of Pediatrics and Professor of Genetics at the Washington University School of Medicine. Dr. Gitlin's speech entitled "Child Health Research in the 21st Century: Obstacles and Opportunities," will address whether diseases such as Alzheimer's, diabetes and obesity are already genetically encoded in individuals while still in the womb, and can possibly be prevented with genetic engineering before birth.

Completing the keynote speaker line-up will be Jeffrey I. Gordon, M.D., the Robert J. Glaser Distinguished University Professor at Washington University School of Medicine. Dr. Gordon's speech is entitled "Dining in With a Few Trillion Friends: Exploring the Human Gut Microbiota and Microbiome." Dr. Gordon has also served as the head of molecular biology and pharmacology at Washington University School of Medicine and was director of the University's division of biology and biomedical sciences.

The Society for Biomolecular Sciences (SBS) is the only international non-profit scientific society dedicated to drug discovery and its related disciplines. Founded in 1994, the Society provides a forum for global education and information exchange among professionals in the chemical, pharmaceutical, biotech and agrochemical industries. SBS was developed in an effort to advance the science of drug discovery and related disciplines by providing a forum for education and information exchange among professionals around the world.

For further information on the SBS 14th Annual Conference and Exhibition, visit http://www.sbsonline.org or contact Jennifer Bender or Rosalind D'Eugenio at (203) 325-8772, or jbender@environics-usa.com.


'/>"/>
SOURCE Society for Biomolecular Sciences
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. News from the March 2008 American Physical Society Meeting
2. Professor Toh-Ming Lu named fellow of the Materials Research Society
3. Angiotech showcases its Hemostream(TM) Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting
4. Alseres Pharmaceuticals Presents Inosine and Dopamine Transporter (DAT) Blocker Preclinical Data at the American Society for Experimental NeuroTherapeutics (ASENT) Conference
5. Complete ANX-530 Safety Data to be Published in the 2008 Proceedings of the American Society of Clinical Oncology
6. Society for Biological Engineering Holds First International Conference on Stem Cell Engineering
7. Arizona Pain Society and Dr. Robert Barkin, Rush University Medical Center, Present Program on Comprehensive Urine Drug Testing Sponsored by Dominion Diagnostics
8. ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting
9. 49th Annual Meeting of the American Society of Hematology Will Feature the Latest Research in Blood Diseases
10. ThromboGenics Presents Results of the Vitreomacular Traction Trial (MIVI IIT) at the American Society of Retina Specialists Annual Meeting
11. Three Astex Drug Candidates to be Presented at the 2007 American Society of Hematology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Orleans, La. (PRWEB) , ... March 23, 2017 ... ... real-time, industrial monitoring solutions, today announced the hire of Dr. Sigmund “Sig” Floyd ... APMT customer applications, strategic partnerships and joint development activities. , “Dr. Floyd’s career ...
(Date:3/22/2017)... COPENHAGEN, Denmark , March 22, 2017 /PRNewswire/ ... that utilizes its innovative TransCon technology to address ... announced financial results for the full year ended ... a significant year for our company as we ... become a leading, integrated rare disease company with ...
(Date:3/22/2017)... 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... ), a clinical-stage pharmaceutical company focused ... announced today that Dr. Miriam Kidron , ... titled, "Oral Insulin for Diabetes Treatment: Bypassing the ... and Peptide Therapeutics (OPT) Boston Conference in ...
(Date:3/22/2017)... Florida , March 22, 2017 ... ... various cancer conditions are being pressured as of late due ... for cancer pain management has a dramatic impact on patient,s ... research and development activities for identifying new forms of opioid ...
Breaking Biology Technology:
(Date:3/23/2017)... 23, 2017 The report "Gesture Recognition and Touchless Sensing ... Geography - Global Forecast to 2022", published by MarketsandMarkets, the market is expected ... 29.63% between 2017 and 2022. Continue Reading ... ... ...
(Date:3/22/2017)... VILNIUS, Lithuania , March 21, 2017 /PRNewswire/ ... identification and object recognition technologies, today announced the ... development kit (SDK), which provides improved facial recognition ... safety cameras on a single computer. The new ... algorithms to improve accuracy, and it utilizes a ...
(Date:3/22/2017)... Vigilant Solutions , a vehicle location ... announced today the appointment of retired FBI special agent ... business development. Mr. Sheridan brings more than ... focus on the aviation transportation sector, to his new ... Sheridan served as the Aviation Liaison Agent Coordinator (ALAC) ...
Breaking Biology News(10 mins):